Imagion Biosystems Limited
ASX:IBX.AX
Overview | Financials
Company Name | Imagion Biosystems Limited |
Symbol | IBX.AX |
Currency | AUD |
Price | 0.053 |
Market Cap | 2,281,051 |
Dividend Yield | 0% |
52-week-range | 0.022 - 0.48 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Isaac J. Bright M.D. |
Website | https://imagionbiosystems.com |
An error occurred while fetching data.
About Imagion Biosystems Limited
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD